Mackenzie Financial Corp Dr Reddys Laboratories LTD Transaction History

Mackenzie Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	BUY	$36.66 - $41.78 $1.36 Million - $1.55 Million	37,100 New	37,100 $1.51 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $486,674 - $577,260	-13,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$35.77 - $40.57 $482,895 - $547,695	13,500 New	13,500 $547,000
Q4 2018 Feb 06, 2019	SELL	$31.89 - $38.44 $639,713 - $771,106	-20,060 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$29.25 - $36.73 $218,205 - $274,005	7,460 Added 59.21%	20,060 $694,000
Q2 2018 Aug 13, 2018	BUY	$28.49 - $35.06 $358,974 - $441,756	12,600 New	12,600 $406,000

250

23.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.47B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.